|
1
|
Zhiqin W, Palaniappan S and Ali Raja RA:
Inflammatory bowel disease-related colorectal cancer in the
asia-pacific region: Past, present, and future. Intest Res.
12:194–204. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Aklilu M and Eng C: The current landscape
of locally advanced rectal cancer. Nat Rev Clin Oncol. 8:649–659.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Volck B, Price PA, Johansen JS, Sørensen
O, Benfield TL, Nielsen HJ, Calafat J and Borregaard N: YKL-40, a
mammalian member of the chitinase family, is a matrix protein of
specific granules in human neutrophils. Proc Assoc Am Physicians.
110:351–360. 1998.PubMed/NCBI
|
|
4
|
Junker N, Johansen JS, Andersen CB and
Kristjansen PE: Expression of YKL-40 by peritumoral macrophages in
human small cell lung cancer. Lung Cancer. 48:223–231. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Johansen JS, Schultz NA and Jensen BV:
Plasma YKL-40: A potential new cancer biomarker? Future Oncol.
5:1065–1082. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Johansen JS, Høyer PE, Larsen LA, Price PA
and Møllgård K: YKL-40 protein expression in the early developing
human musculoskeletal system. J Histochem Cytochem. 55:1213–1228.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Brøchner CB, Johansen JS, Larsen LA, Bak
M, Mikkelsen HB, Byskov AG, Andersen CY and Møllgård K: YKL-40 is
differentially expressed in human embryonic stem cells and in cell
progeny of the three germ layers. J Histochem Cytochem. 60:188–204.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Francescone RA, Scully S, Faibish M,
Taylor SL, Oh D, Moral L, Yan W, Bentley B and Shao R: Role of
YKL-40 in the angiogenesis, radioresistance, and progression of
glioblastoma. J Biol Chem. 286:15332–15343. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lee CG, Hartl D, Lee GR, Koller B,
Matsuura H, Da Silva CA, Sohn MH, Cohn L, Homer RJ, Kozhich AA, et
al: Role of breast regression protein 39 (BRP-39)/Chitinase
3-like-1 in Th2 and IL-13-induced tissue responses and apoptosis. J
Exp Med. 206:1149–1166. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Thongsom S, Chaocharoen W, Silsirivanit A,
Wongkham S, Sripa B, Choe H, Suginta W and Talabnin C:
YKL-40/chitinase-3-like protein 1 is associated with poor prognosis
and promotes cell growth and mgration of cholangiocarcinoma. Tumour
Biol. 37:9451–9463. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Chiang YC, Lin HW, Chang CF, Chang MC, Fu
CF, Chen TC, Hsieh SF, Chen CA and Cheng WF: Overexpression of
CHI3L1 is associated with chemoresistance and poor outcome of
epithelial ovarian carcinoma. Oncotarget. 6:39740–39755. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zheng X, Xing S, Liu XM, Liu W, Liu D, Chi
PD, Chen H, Dai SQ, Zhong Q, Zeng MS and Liu WL: Establishment of
using serum YKL-40 and SCCA in combination for the diagnosis of
patients with esophageal squamous cell carcinoma. BMC Cancer.
14:4902014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wang D, Zhai B, Hu F, Liu C, Zhao J and Xu
J: High YKL-40 serum concentration is correlated with prognosis of
Chinese patients with breast cancer. PLoS One. 7:e511272012.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kırankaya Güneş A, Gül Ş, Tutar N, Özgül
MA, Çetinkaya E, Zengi O and Onaran H: The place of YKL-40 in
non-small cell lung cancer. Tuberk Toraks. 62:273–278. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhu CB, Wang C, Chen LL, Ma GL, Zhang SC,
Su L, Tian JJ and Gai ZT: Serum YKL-40 independently predicts
outcome after transcatheter arterial chemoembolization of
hepatocellular carcinoma. PLoS One. 7:e446482012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Vom Dorp F, Tschirdewahn S, Niedworok C,
Reis H, Krause H, Kempkensteffen C, Busch J, Kramer G, Shariat SF,
Nyirady P, et al: Circulating and tissue expression levels of
YKL-40 in renal cell cancer. J Urol. 195:1120–1125. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Johansen JS, Christensen IJ, Jørgensen LN,
Olsen J, Rahr HB, Nielsen KT, Laurberg S, Brünner N and Nielsen HJ:
Serum YKL-40 in risk assessment for colorectal cancer: A
prospective study of 4,496 subjects at risk of colorectal cancer.
Cancer Epidemiol Biomarkers Prev. 24:621–626. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Chen CC, Llado V, Eurich K, Tran HT and
Mizoguchi E: Carbohydrate-binding motif in chitinase 3-like 1
(CHI3L1/YKL-40) specifically activates Akt signaling pathway in
colonic epithelial cells. Clin Immunol. 140:268–275. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Chen CC, Pekow J, Llado V, Kanneganti M,
Lau CW, Mizoguchi A, Mino-Kenudson M, Bissonnette M and Mizoguchi
E: Chitinase 3-like-1 expression in colonoic epithelial cells as a
potentially novel marker for colitis-associated neoplasia. Am J
Pathol. 179:1494–1503. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kraus S and Arber N: Inflammation and
colorectal cancer. Curr Opin Pharmacol. 9:405–410. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Shao R, Hamel K, Petersen L, Cao QJ,
Arenas RB, Bigelow C, Bentley B and Yan W: YKL-40, a secreted
glycoprotein, promotes tumor angiogenesis. Oncogene. 28:4456–4468.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Recklies AD, White C and Ling H: The
chitinase 3-like protein human cartilage glycoprotein 39 (HC-gp39)
stimulates proliferation of human connective-tissue cells and
activates both extracellular signal-regulated kinase- and protein
kinase B-mediated signaling pathways. Biochem J. 365:119–126. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Lee CG, Da Silva CA, Dela Cruz CS,
Ahangari F, Ma B, Kang MJ, He CH, Takyar S and Elias JA: Role of
chitin and chitinase/chitin-like proteins in inflammation, tissue
remodeling, and injury. Annu Rev Physiol. 73:479–501. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Low D, Subramaniam R, Lin L, Aomatsu T,
Mizoguchi A, Ng A, DeGruttola AK, Lee CG, Elias JA, Andoh A, et al:
Chitinase 3-like 1 induces survival and proliferation of intestinal
epithelial cells during chronic inflammation and colitis-associated
cancer by regulating S100A9. Oncotarget. 6:36535–36550. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Okubo S, Uto T, Goto A, Tanaka H, Nishioku
T, Yamada K and Shoyama Y: Berberine induces apoptotic cell death
via activation of caspase-3 and −8 in HL-60 human leukemia cells:
Nuclear localization and structure-activity relationships. Am J
Chin Med. 45:1497–1511. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Lee IA, Kamba A, Low D and Mizoguchi E:
Novel methylxanthine derivative-mediated anti-inflammatory effects
in inflammatory bowel disease. World J Gastroenterol. 20:1127–1138.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Chang YL, Hsu YJ, Chen Y, Wang YW and
Huang SM: Theophylline exhibits anti-cancer activity via
suppressing SRSF3 in cervical and breast cancer cell lines.
Oncotarget. 8:101461–101474. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Sheng H, Shao J, Townsend CM Jr and Evers
BM: Phosphatidylinositol 3-kinase mediates proliferative signals in
intestinal epithelial cells. Gut. 52:1472–1478. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Eurich K, Segawa M, Toei-Shimizu S and
Mizoguchi E: Potential role of chitinase 3-like-1 in
inflammation-associated carcinogenic changes of epithelial cells.
World J Gastroenterol. 15:5249–5259. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Mihalache A and Rogoveanu I: Angiogenesis
factors involved in the pathogenesis of colorectal cancer. Curr
Health Sci J. 40:5–11. 2014.PubMed/NCBI
|
|
31
|
Hu B and Cheng SY: Angiopoietin-2:
Development of inhibitors for cancer therapy. Curr Oncol Rep.
11:111–116. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Fawzy A, Gaafar R, Kasem F, Ali SS,
Elshafei M and Eldeib M: Importance of serum levels of
angiopoietin-2 and survivin biomarkers in non-small cell lung
cancer. J Egypt Natl Cancer Inst. 24:41–45. 2012. View Article : Google Scholar
|
|
33
|
Li C, Sun CJ, Fan JC, Geng N, Li CH, Liao
J, Mi K, Zhu GQ, Ma H, Song YF, et al: Angiopoietin-2 expression is
correlated with angiogenesis and overall survival in oral squamous
cell carcinoma. Med Oncol. 30:5712013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Chen HH, Weng BQ, Cheng KJ, Liu HY, Wang
SQ and Lu YY: Effect of the vascular endothelial growth factor
expression level on angiopoietin-2-mediated nasopharyngeal
carcinoma growth. Vasc Cell. 6:42014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Rautiola J, Lampinen A, Mirtti T,
Ristimäki A, Joensuu H, Bono P and Saharinen P: Association of
angiopoietin-2 and Ki-67 expression with vascular density and
sunitinib response in metastatic renal cell carcinoma. PLoS One.
11:e01537452016. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Goede V, Coutelle O, Neuneier J,
Reinacher-Schick A, Schnell R, Koslowsky TC, Weihrauch MR, Cremer
B, Kashkar H, Odenthal M, et al: Identification of serum
angiopoietin-2 as a biomarker for clinical outcome of colorectal
cancer patients treated with bevacizumab-containing therapy. Br J
Cancer. 103:1407–1414. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Liu WX, Gu SZ, Zhang S, Ren Y, Sang LX and
Dai C: Angiopoietin and vascular endothelial growth factor
expression in colorectal disease models. World J Gastroenterol.
21:2645–2650. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Falcón BL, Hashizume H, Koumoutsakos P,
Chou J, Bready JV, Coxon A, Oliner JD and McDonald DM: Contrasting
actions of selective inhibitors of angiopoietin-1 and
angiopoietin-2 on the normalization of tumor blood vessels. Am J
Pathol. 1755:2159–2170. 2009. View Article : Google Scholar
|
|
39
|
Lobov IB, Brooks PC and Lang RA:
Angiopoietin-2 displays VEGF-dependent modulation of capillary
structure and endothelial cell survival in vivo. Proc Natl Acad Sci
USA. 99:11205–11210. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Li C, Li Q, Cai Y, He Y, Lan X, Wang W,
Liu J, Wang S, Zhu G, Fan J, et al: Overexpression of angiopoietin
2 promotes the formation of oral squamous cell carcinoma by
increasing epithelial-mesenchymal transition-induced angiogenesis.
Cancer Gene Ther. 23:295–302. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Huang H, Lai JY, Do J, Liu D, Li L, Del
Rosario J, Doppalapudi VR, Pirie-Shepherd S, Levin N, Bradshaw C,
et al: Specifically targeting angiopoietin-2 inhibits angiogenesis,
Tie2-expressing monocyte infiltration, and tumor growth. Clin
Cancer Res. 17:1001–1011. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Mazzieri R, Pucci F, Moi D, Zonari E,
Ranghetti A, Berti A, Politi LS, Gentner B, Brown JL, Naldini L and
De Palma M: Targeting the ANG2/TIE2 axis inhibits tumor growth and
metastasis by impairing angiogenesis and disabling rebounds of
proangiogenic myeloid cells. Cancer Cell. 19:512–526. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Monk BJ, Poveda A, Vergote I, Raspagliesi
F, Fujiwara K, Bae DS, Oaknin A, Ray-Coquard I, Provencher DM,
Karlan BY, et al: Anti-angiopoietin therapy with trebananib for
recurrent ovarian cancer (TRINOVA-1): A randomised, multicentre,
double-blind, placebo-controlled phase 3 trial. Lancet Oncol.
15:799–808. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Riabov V, Gudima A, Wang N, Mickley A,
Orekhov A and Kzhyshkowska J: Role of tumor associated macrophage
in tumor angiogenesis and lymphangiogenesis. Front Physiol.
5:752014. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Nishikawa KC and Millis AJ: gp38k (CHI3L1)
is a novel adhesion and migration factor for vascular cells. Exp
Cell Res. 287:79–87. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Ngernyuang N, Francescone RA, Jearanaikoon
P, Daduang J, Supoken A, Yan W, Shao R and Limpaiboon T: Chitinase
3 like 1 is associated with tumor angiogenesis in cervical cancer.
Int J Biochem Cell Biol. 51:45–52. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Zhang JP, Yuan HX, Kong WT, Liu Y, Lin ZM,
Wangs WP and Guo JM: Increased expression of Chitinase 3-like 1 and
microvessel density predicts metastasis and poor prognosis in clear
cell renal cell carcinoma. Tumour Biol. 35:12131–12137. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Kawada M, Seno H, Kanda K, Nakanishi Y,
Akitake R, Komekado H, Kawada K, Sakai Y, Mizoguchi E and Chiba T:
Chitinase 3-like 1 promotes macrophage recruitment and angiogenesis
in colorectal cancer. Oncogene. 31:3111–3123. 2012. View Article : Google Scholar : PubMed/NCBI
|
